Edison Investment Research Limited · ISIN: GB0000385517 · EQS - Company News

Edison issues report on The Biotech Growth Trust (BIOG)

  London, UK, 20 August 2024   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) Click here to read the full report. All reports published by Edison are available to download free of charge from its website www.edisongroup.com Edison is authorised and regulated by the Financial Conduct Authority. Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy...

LSE:BIOG Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Edison Investment Research Limited

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
20 August 2024 01:07PM
Edison issues report on The Biotech Growth Trust (BIOG)
GB0000385517
  London, UK, 20 August 2024   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) Click here to read the full report. All reports published by Edison are available to download free of charge from its website www.edisongroup.com Edison is authorised and regulated by the Financi...
Edison Investment Research Limited
About the publication
20 March 2024 10:09AM
Onwards and upwards for performance recovery
GB0000385517
  London, UK, 20 March 2024   Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery The Biotech Growth Trust’s (BIOG’s) two co-managers, Geoff Hsu and Josh Golomb, at global healthcare specialist OrbiMed, believe that now could be an opportune time to consider the biotech sector as it is recoverin...
Edison Investment Research Limited
About the publication
More Edison Investment Research Limited related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN